BO 2367

a topoisomerase II inhibitor; RN given refers to (-)-isomer; structure given in first source

Also Known As:

(-)-7-((1R*,2R*,6R*)-2-amino-8-azabicyclo(4.3.0.)-non-3-en-8-yl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; BO 2367, (+)-isomer; BO-2367

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Quinolones: 2938
        Fluoroquinolones: 5348
        BO 2367: 1

Related Diseases

1.	Neoplasms (Cancer) 07/01/1993 - "Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367."

Related Drugs and Biologics

1.	Quinolones
2.	Type II DNA Topoisomerases (Topoisomerase II)